Dako, an Agilent Technologies company, has signed an agreement to acquire the intellectual property rights behind connectivity software from California-based software development company System Dynamics, Inc. (SDI). The SDI development team joins Dako and brings new software development competencies to one of the world’s leaders in cancer diagnostics.

“The acquisition of the intellectual property rights behind Laboratory Information System (LIS) connectivity software is an important milestone for Dako in our efforts to further strengthen our position and capabilities in LIS connectivity. Moreover, the SDI team will bring important competencies to Dako, ensuring our ability to continue the development of the DakoLink solution to the benefit of our customers in pathology laboratories around the world,” says Jacob Thaysen, CVP Dako R&D.

SDI is a longtime business partner and supplier to Dako. Dako and SDI have worked together for 12 years on the design and development of the DakoLink software for use in Dako’s Autostainer and Artisan instruments. SDI has also been instrumental in the design of the LIS connectivity product ULISA, which Dako uses to connect the DakoLink solution to LIS systems at more than 150 sites around the world. The agreement provides Dako and Agilent with ownership and control of the intellectual property behind the LIS connectivity software.

About System Dynamics, Inc.

System Dynamics was founded in 1985 as an industrial system integrator specializing in custom microcomputer software for quality and process control applications. Since 2003 the company has focused on medical instrument software and bioinformatics, including technologies such as Laboratory Information System (LIS) connectivity. System Dynamics’ offices are located in Santa Barbara, CA, USA. Synergy Advisors, LLC represented System Dynamics, Inc. as its M&A advisor in this transaction.

About Dako, An Agilent Technologies Company

Dako, based in Denmark, is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako’s reagents, instruments, software and expertise to make accurate diagnoses and determine the most effective treatment for cancer patients. Dako, with 1,200 employees, operates in more than 100 countries. Dako became part of Agilent Technologies on June 21, 2012. www.dako.com

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,500 employees serve customers in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal 2012. www.agilent.com.